Legal & General Group
TBIO

Legal & General Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Legal & General Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-23,213
Closed -$639K – 3522
2021
Q2 		$639K Sell
23,213
-107
-0.5% -$2.1K ﹤0.01% 2297
2021
Q1 		$385K Buy
23,320
+1,180
+5% +$26.9K ﹤0.01% 2339
2020
Q4 		$408K Sell
22,140
-136
-0.6% -$2.43K ﹤0.01% 2298
2020
Q3 		$304K Sell
22,276
-475
-2% -$7.32K ﹤0.01% 2289
2020
Q2 		$408K Buy
22,751
+4,404
+24% +$66.4K ﹤0.01% 2216
2020
Q1 		$183K Sell
18,347
-1,799
-9% -$14.7K ﹤0.01% 2300
2019
Q4 		$164K Buy
20,146
+15,193
+307% +$140K ﹤0.01% 2446
2019
Q3 		$49K Hold
4,953
– – ﹤0.01% 2744
2019
Q2 		$63K Hold
4,953
– – ﹤0.01% 2683
2019
Q1 		$50K Buy
4,953
+3,469
+234% +$26.6K ﹤0.01% 2714
2018
Q4 		$11K Hold
1,484
– – ﹤0.01% 3263
2018
Q3 		$15K Buy
+1,484
New +$17.3K ﹤0.01% 3275

Legal & General Group's TBIO Position: Q3 2021 in Review

Legal & General Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 23,213 shares — an estimated $639K sold.

Legal & General Group first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $639K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Legal & General Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Legal & General Group sold 23,213 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $639K.
  • Legal & General Group first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Legal & General Group's Translate Bio, Inc. Common Stock position peaked at $639K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.